TP53 truncating mutations were enriched in BRCA1 carriers compared with non‐carriers and showed a trend toward worse outcomes, potentially related to lower homologous recombination deficiency scores and activation of epithelial‐mesenchymal transition pathways.
← all excerpts
Genetic Evolution in BRCA1-Associated Breast Cancer Reveals Early Driver Mutations Shaping Tumor Features and Prognosis.
1
—
—